Ferric Carboxymaltose in Heart Failure with Iron Deficiency
Ferric Carboxymaltose in Heart Failure with Iron Deficiency
About this item
Full title
Author / Creator
Mentz, Robert J. , Garg, Jyotsna , Rockhold, Frank W. , Butler, Javed , De Pasquale, Carmine G. , Ezekowitz, Justin A. , Lewis, Gregory D. , O’Meara, Eileen , Ponikowski, Piotr , Troughton, Richard W. , Wong, Yee Weng , She, Lilin , Harrington, Josephine , Adamczyk, Robert , Blackman, Nicole and Hernandez, Adrian F.
Publisher
Boston: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In patients with heart failure with reduced ejection fraction and iron deficiency, ferric carboxymaltose therapy did not appear to differ from placebo in the composite of death, heart-failure hospitalizations, or walk distance.
Alternative Titles
Full title
Ferric Carboxymaltose in Heart Failure with Iron Deficiency
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2857853529
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2857853529
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2304968
